These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 22138192)

  • 21. Predicting acute radiation induced xerostomia in head and neck Cancer using MR and CT Radiomics of parotid and submandibular glands.
    Sheikh K; Lee SH; Cheng Z; Lakshminarayanan P; Peng L; Han P; McNutt TR; Quon H; Lee J
    Radiat Oncol; 2019 Jul; 14(1):131. PubMed ID: 31358029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic accuracy of ultrasonic histogram features to evaluate radiation toxicity of the parotid glands: a clinical study of xerostomia following head-and-neck cancer radiotherapy.
    Yang X; Tridandapani S; Beitler JJ; Yu DS; Chen Z; Kim S; Bruner DW; Curran WJ; Liu T
    Acad Radiol; 2014 Oct; 21(10):1304-13. PubMed ID: 25088832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Texture analysis as a predictor of radiation-induced xerostomia in head and neck patients undergoing IMRT.
    Nardone V; Tini P; Nioche C; Mazzei MA; Carfagno T; Battaglia G; Pastina P; Grassi R; Sebaste L; Pirtoli L
    Radiol Med; 2018 Jun; 123(6):415-423. PubMed ID: 29368244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A quantitative assessment of volumetric and anatomic changes of the parotid gland during intensity-modulated radiotherapy for head and neck cancer using serial computed tomography.
    Ajani AA; Qureshi MM; Kovalchuk N; Orlina L; Sakai O; Truong MT
    Med Dosim; 2013; 38(3):238-42. PubMed ID: 23558146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: the role of dosimetric and clinical factors.
    Beetz I; Schilstra C; van der Schaaf A; van den Heuvel ER; Doornaert P; van Luijk P; Vissink A; van der Laan BF; Leemans CR; Bijl HP; Christianen ME; Steenbakkers RJ; Langendijk JA
    Radiother Oncol; 2012 Oct; 105(1):101-6. PubMed ID: 22516776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Xerostomia after radiotherapy. What matters--mean total dose or dose to each parotid gland?
    Tribius S; Sommer J; Prosch C; Bajrovic A; Muenscher A; Blessmann M; Kruell A; Petersen C; Todorovic M; Tennstedt P
    Strahlenther Onkol; 2013 Mar; 189(3):216-22. PubMed ID: 23354440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Texture analysis for the assessment of structural changes in parotid glands induced by radiotherapy.
    Scalco E; Fiorino C; Cattaneo GM; Sanguineti G; Rizzo G
    Radiother Oncol; 2013 Dec; 109(3):384-7. PubMed ID: 24183861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer.
    Bussels B; Maes A; Hermans R; Nuyts S; Weltens C; Van den Bogaert W
    Radiother Oncol; 2004 Aug; 72(2):119-27. PubMed ID: 15297131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of dose on parotid salivary recovery in head and neck cancer patients treated with radiation therapy.
    Li Y; Taylor JM; Ten Haken RK; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):660-9. PubMed ID: 17141973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Xerostomia in long-term survivors of aggressive non-Hodgkin's lymphoma of Waldeyer's ring: a potential role for parotid-sparing techniques?
    Chang DT; Amdur RJ; Pacholke H; Mendenhall NP; Morris CG; Byer GA; Olivier KR
    Am J Clin Oncol; 2009 Apr; 32(2):145-9. PubMed ID: 19307951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Density variation of parotid glands during IMRT for head-neck cancer: correlation with treatment and anatomical parameters.
    Fiorino C; Rizzo G; Scalco E; Broggi S; Belli ML; Dell'Oca I; Dinapoli N; Ricchetti F; Rodriguez AM; Di Muzio N; Calandrino R; Sanguineti G; Valentini V; Cattaneo GM
    Radiother Oncol; 2012 Aug; 104(2):224-9. PubMed ID: 22809587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early changes of parotid density and volume predict modifications at the end of therapy and intensity of acute xerostomia.
    Belli ML; Scalco E; Sanguineti G; Fiorino C; Broggi S; Dinapoli N; Ricchetti F; Valentini V; Rizzo G; Cattaneo GM
    Strahlenther Onkol; 2014 Oct; 190(11):1001-7. PubMed ID: 24756139
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    van Dijk LV; Noordzij W; Brouwer CL; Boellaard R; Burgerhof JGM; Langendijk JA; Sijtsema NM; Steenbakkers RJHM
    Radiother Oncol; 2018 Jan; 126(1):89-95. PubMed ID: 28951007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preservation of parotid function with uncomplicated conformal radiotherapy.
    Maes A; Weltens C; Flamen P; Lambin P; Bogaerts R; Liu X; Baetens J; Hermans R; Van den Bogaert W
    Radiother Oncol; 2002 May; 63(2):203-11. PubMed ID: 12063010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A study on the impact of patient-related parameters in the ability to spare parotid glands by intensity-modulated radiotherapy for head and neck squamous cell carcinomas.
    Bandlamudi BP; Sharan K; Yathiraj PH; Singh A; Reddy A; Fernandes DJ; Srinivasa VM
    J Cancer Res Ther; 2018; 14(6):1220-1224. PubMed ID: 30488833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without Amifostine.
    Münter MW; Hoffner S; Hof H; Herfarth KK; Haberkorn U; Rudat V; Huber P; Debus J; Karger CP
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):651-9. PubMed ID: 17175118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early prediction of radiotherapy-induced parotid shrinkage and toxicity based on CT radiomics and fuzzy classification.
    Pota M; Scalco E; Sanguineti G; Farneti A; Cattaneo GM; Rizzo G; Esposito M
    Artif Intell Med; 2017 Sep; 81():41-53. PubMed ID: 28325604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intensity-modulated radiotherapy in head and neck cancer: results of the prospective study GORTEC 2004-03.
    Toledano I; Graff P; Serre A; Boisselier P; Bensadoun RJ; Ortholan C; Pommier P; Racadot S; Calais G; Alfonsi M; Favrel V; Giraud P; Lapeyre M
    Radiother Oncol; 2012 Apr; 103(1):57-62. PubMed ID: 22296746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of parotid gland irradiation in the development of severe hyposalivation (xerostomia) after intensity-modulated radiation therapy for head and neck cancer: Temporal patterns, risk factors, and testing the QUANTEC guidelines.
    Owosho AA; Thor M; Oh JH; Riaz N; Tsai CJ; Rosenberg H; Varthis S; Yom SH; Huryn JM; Lee NY; Deasy JO; Estilo CL
    J Craniomaxillofac Surg; 2017 Apr; 45(4):595-600. PubMed ID: 28256385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using a reduced spot size for intensity-modulated proton therapy potentially improves salivary gland-sparing in oropharyngeal cancer.
    van de Water TA; Lomax AJ; Bijl HP; Schilstra C; Hug EB; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e313-9. PubMed ID: 21708427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.